Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1985 May;27(5):724–726. doi: 10.1128/aac.27.5.724

Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro.

S Benes, W M McCormack
PMCID: PMC180141  PMID: 2990322

Abstract

We evaluated the ability of the widely used spermicide nonoxynol-9, Conceptrol gel containing nonoxynol-9, and Conceptrol vehicle (without nonoxynol-9) to inhibit the formation of inclusions of Chlamydia trachomatis in cycloheximide-treated McCoy cells. Conceptrol vehicle produced a non-dose-related 40 to 59% reduction of the number of inclusions formed. In contrast, the addition of nonoxynol-9 and Conceptrol gel containing nonoxynol-9 at a concentration of 100 micrograms/ml reduced the number of inclusions by 84 to 95%. Prolongation of contact between nonoxynol-9 and the chlamydial organisms from 90 to 180 min did not result in additional inhibition. Using a higher concentration of chlamydial organisms and diluting the drug-chlamydia mixture before inoculation of the monolayers, we were able to test higher concentrations of nonoxynol-9. At concentrations of 100 to 5,000 micrograms of nonoxynol-9 per ml, a dose-related 19 to 84% reduction of the number of inclusions was noted.

Full text

PDF
726

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asculai S. S., Weis M. T., Rancourt M. W., Kupferberg A. B. Inactivation of herpes simplex viruses by nonionic surfactants. Antimicrob Agents Chemother. 1978 Apr;13(4):686–690. doi: 10.1128/aac.13.4.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benes S., McCormack W. M. Comparison of methods for cultivation and isolation of Chlamydia trachomatis. J Clin Microbiol. 1982 Nov;16(5):847–850. doi: 10.1128/jcm.16.5.847-850.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Donsky H. J. Nonoxynol 9 cream for genital herpes simplex. N Engl J Med. 1979 Feb 15;300(7):371–371. doi: 10.1056/nejm197902153000724. [DOI] [PubMed] [Google Scholar]
  4. Jick H., Hannan M. T., Stergachis A., Heidrich F., Perera D. R., Rothman K. J. Vaginal spermicides and gonorrhea. JAMA. 1982 Oct 1;248(13):1619–1621. [PubMed] [Google Scholar]
  5. Mårdh P. A., Wølner-Hanssen P. Three novel manifestations of chlamydia trachomatis infection- endometritis, perihepatitis and meningoencephalitis. Infection. 1982;10 (Suppl 1):S57–S60. doi: 10.1007/BF01640716. [DOI] [PubMed] [Google Scholar]
  6. STONE A., GAMBLE C. J. The quantity of vaginal fluid. Am J Obstet Gynecol. 1959 Aug;78(2):279–281. doi: 10.1016/0002-9378(59)90173-5. [DOI] [PubMed] [Google Scholar]
  7. Schachter J. Chlamydial infections (third of three parts). N Engl J Med. 1978 Mar 9;298(10):540–549. doi: 10.1056/NEJM197803092981005. [DOI] [PubMed] [Google Scholar]
  8. Singh B., Posti B., Cutler J. C. Virucidal effect of certain chemical contraceptives on Type 2 herpesvirus. Am J Obstet Gynecol. 1976 Oct 15;126(4):422–425. doi: 10.1016/0002-9378(76)90630-x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES